View in EDS PDF Full Text

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.

Saved in:
Bibliographic Details
Title: Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.
Authors: Siurala M; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Vähä-Koskela M; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Havunen R; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Tähtinen S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Bramante S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland., Parviainen S; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Mathis JM; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University , Baton Rouge, LA, USA., Kanerva A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital (HUCH), Helsinki, Finland., Hemminki A; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Source: Oncoimmunology [Oncoimmunology] 2016 Feb 18; Vol. 5 (5), pp. e1136046. Date of Electronic Publication: 2016 Feb 18 (Print Publication: 2016).
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27467954
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Siurala+M%22">Siurala M</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Vähä-Koskela+M%22">Vähä-Koskela M</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Havunen+R%22">Havunen R</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Tähtinen+S%22">Tähtinen S</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Bramante+S%22">Bramante S</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki , Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Parviainen+S%22">Parviainen S</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Mathis+JM%22">Mathis JM</searchLink>; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University , Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22Kanerva+A%22">Kanerva A</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital (HUCH), Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Hemminki+A%22">Hemminki A</searchLink>; Cancer Gene Therapy Group, Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2016 Feb 18; Vol. 5 (5), pp. e1136046. <i>Date of Electronic Publication: </i>2016 Feb 18 (<i>Print Publication: </i>2016).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27467954
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2015.1136046
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1136046
    Titles:
      – TitleFull: Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Siurala M
      – PersonEntity:
          Name:
            NameFull: Vähä-Koskela M
      – PersonEntity:
          Name:
            NameFull: Havunen R
      – PersonEntity:
          Name:
            NameFull: Tähtinen S
      – PersonEntity:
          Name:
            NameFull: Bramante S
      – PersonEntity:
          Name:
            NameFull: Parviainen S
      – PersonEntity:
          Name:
            NameFull: Mathis JM
      – PersonEntity:
          Name:
            NameFull: Kanerva A
      – PersonEntity:
          Name:
            NameFull: Hemminki A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2016 Feb 18
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1